Skip to main content
SpringerLink
Log in

1-Phenoxyalkyl-4-[(N,N-disubstitutedamino)alkyl]piperazine derivatives as non-imidazole histamine H3-antagonists

  • Original Research
  • Published:
Medicinal Chemistry Research Aims and scope Submit manuscript

Abstract

In this study, a series of 1-phenoxyalkyl-4-[(N,N-disubstitutedamino)alkyl]piperazine derivatives has been prepared and in vitro tested as H3-receptor antagonists (electrically evoked contraction of the guinea pig jejunum). All compounds investigated show moderate in vitro affinities. The most potent antagonists in this series are the compounds 9b, 1b, 1f, and 1l, which exhibit, independently of the substituent at the end of -N- moiety, almost the same level of affinity (pA 2 = 7.18, pA 2 = 7.27, pA 2 = 7.13, pA 2 = 7.12, respectively). The histaminergic H1 antagonism of the aforementioned four products was established on the isolated guinea pig ileum by conventional methods; the pA 2 values were compared with the potency of pyrilamine. None of them shows any H1-antagonistic activity (pA 2 < 4; for pyrilamine pA 2 = 9.35).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Chart 1
Scheme 1
Scheme 2
Scheme 3

Similar content being viewed by others

References

  • Alves-Rodrigues A, Leurs R, Wu TS, Prel GD, Foged C, Timmerman H (1996) [3H]-thioperamide as a radioligand for the histamine H H3 receptor in rat cerebral cortex. Br J Pharmacol 118:2045–2052

    Article  PubMed  CAS  Google Scholar 

  • Apodaca R, Dvorac CA, Xiao W, Barbier AJ, Boggs JD, Wilso SJ, Lovenberg TW, Carruthers NI (2003) A new class of diamine-based human histamine H3 receptor antagonists: 4-(aminoalkoxy)benzylamines. J Med Chem 46:3938–3944

    Article  PubMed  CAS  Google Scholar 

  • Arrang JM, Garbarg M, Schwartz JC (1983) Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor. Nature 302:832–837

    Article  PubMed  CAS  Google Scholar 

  • Arrang JM, Garbarg M, Schwartz JC (1985) Autoregulation of histamine release in brain by presynaptic H3-receptors. Neuroscience 15:553–562

    Article  PubMed  CAS  Google Scholar 

  • Arrang JM, Garbarg M, Schwartz JC (1987) Autoinhibition of histamine synthesis mediated by presynaptic H3-receptors. Neuroscience 23:149–157

    Article  PubMed  CAS  Google Scholar 

  • Arunlakshana O, Schild HO (1959) Some quantitative uses of drug antagonists. Br J Pharmacol 14:48–58

    CAS  Google Scholar 

  • Banik BK, Becker FF (2001) Polycyclic aromatic compounds as anticancer agents: structure–activity relationships of chrysene and pyrene derivatives. Bioorg Med Chem 9:593–605

    Article  PubMed  CAS  Google Scholar 

  • Berlin M, Boyce CW, de Lera Ruiz M (2011) Histamine H3 receptor as a drug discovery target. J Med Chem 54:26–53

    Article  PubMed  CAS  Google Scholar 

  • Capuano B, Crosby IT, Lloyd EJ, Podloucka A, Taylor DA (2008) Synthesis and preliminary pharmacological evaluation of 4’-Arylalkyl analogues of Clozapine. IV. The effects of the aromatic and isosteric replacement. Aust J Chem 61:930–940

    Google Scholar 

  • Clapham J, Kilpatrick GJ (1992) Histamine H3-receptors modulate the release of [3H]-acetylcholine from slices of rat entorhinal cortex: evidence for the possible existence of H3-receptor subtypes. J Pharmacol 107:919–923

    CAS  Google Scholar 

  • Collins RF, Davis M (1961) The chemotherapy of schistosomiasis. Part IV. Some ethers of 4-amino-2-methoxyphenol. J Chem Soc (May):1863–1879

  • Cowart M, Faghih R, Curtis MP, Gfesser GA, Bennani YL, Black LA, Pan L, Marsh KC, Sullivan JP, Esbenshade TA, Fox GB, Hancock AA (2005) 4-(2-[2-(2(R)-Methylpyrrolidin-1-yl)ethyl]benzofuran-5-yl)benzonitrile and related 2-aminoethylbenzofuran H3 receptor antagonists potently enhance cognition and attention. J Med Chem 48:38–55

    Article  PubMed  CAS  Google Scholar 

  • Frymarkiewicz A, Walczyński K (2009) Non-imidazole histamine H3 ligands, part IV: SAR of 1-[2-thiazol-5-yl-(2-aminoethyl)]-4-n-propylpiperazine derivatives. Eur J Med Chem 44:1674–1681

    Article  PubMed  CAS  Google Scholar 

  • Glase SA, Robertson DW, Wise LD (2002) Attention deficit hyperactivity disorder: Pathophysiology and design of new treatments. Annu Rep Med Chem 37:11–20

    Google Scholar 

  • Kieć-Kononowicz K, Ligneau X, Stark H, Schwartz JC, Schunack W (1995) Azines and diazines as potential histamine H3-receptor antagonists. Arch Pharm Med Chem 328:445–450

    Article  Google Scholar 

  • Labella FS, Queen G, Glavin G, Durant G, Stein D, Brandes IJ (1992) H3 receptor antagonist, thioperamide, inhibits adrenal steroidogenesis and histamine binding to adrenocortical microsomes and binds to cytochrome P450. Br J Pharmacol 107:161–164

    Article  PubMed  CAS  Google Scholar 

  • Lehman MR, Thompson CD, Marvel CS (1933) Quaternary ammonium salts from halogenated alkyl dimethylamines. III. omega-bromo-heptyl-, -octyl-, -nonyl- and -decyl-dimethylamines. J Am Chem Soc 55:1977–1981

    Article  CAS  Google Scholar 

  • Leurs R, Tulup MT, Menge WM, Adolfs MJ, Zuiderveld OP, Timmerman H (1995) Evaluation of receptor selectivity of the H3 receptor antagonists, iodophenpropit and thioperamide: an interaction with the 5-HT3 receptor revealed. Br J Pharmacol 116:2315–2321

    Article  PubMed  CAS  Google Scholar 

  • Leurs R, Blandina P, Tedford C, Timmerman H (1998) Therapeutic potential of histamine H3 receptor agonists and antagonists. Trends Pharmacol Sci 19:177–183

    Article  PubMed  CAS  Google Scholar 

  • Leurs R, Bakker RA, Timmerman H, de Esch IJ (2005) The histamine H3 receptor: from gene cloning to H3 receptor drugs. Nat Rev Drug Discov 4:107–120

    Article  PubMed  CAS  Google Scholar 

  • Ligneau X, Lin J, Vanni-Mercier G, Jouvet M, Muir JL, Ganellin CR, Stark H, Elz S, Schunack W, Schwartz JC (1998) Neurochemical and behavioral effects of ciproxifan, a potent histamine H3-receptor antagonist. J Pharmacol Exp Therap 287:658–666

    CAS  Google Scholar 

  • Ligneau X, Morriset S, Tradivel-Lacombe J, Gbabou F, Ganellin CR, Stark H, Schunack W, Schwartz JC, Arrang JM (2000) Distinct pharmacology of rat and human histamine H3 receptors: role of two amino acids in the third transmembrane domain. Br J Pharmacol 131:1247–1250

    Article  PubMed  CAS  Google Scholar 

  • Littmann ER, Marvel CS (1930) Cyclic quaternary ammonium salts from halogenated aliphatic tertiary amines. J Am Chem Soc 52:287–294

    Article  CAS  Google Scholar 

  • Liu C, Ma X, Jiang X, Wilson SJ, Hofistra CI, Blevit J, Pyati J, Li XB, Chai WY, Carruthers N, Lovenberg TW (2001) Cloning and pharmacological characterization of a fourth histamine receptor (H4) expressed in bone marrow. Mol Pharmacol 59:420–426

    PubMed  CAS  Google Scholar 

  • Lovenberg TW, Roland BL, Wilson SJ, Jiang X, Pyati J, Huvar A, Jackson MR, Erlander MG (1999) Accelerated communication: cloning and functional expression of the human histamine H3 receptor. Mol Pharmacol 55:1101–1107

    PubMed  CAS  Google Scholar 

  • Lovenberg TW, Pyti J, Chang H, Wilson SJ, Erlander MG (2000) Cloning of rat histamine H3 receptor reveals distinct species pharmacological profiles. J Pharmacol Exp Therap 293:771–778

    CAS  Google Scholar 

  • Meier G, Apelt J, Reichert U, Grassman S, Ligneau X, Elz S, Leurguin F, Ganellin CR, Schwartz JC, Schunack W, Stark H (2001) Influence of imidazole replacement in different structural classes of histamine H3-receptor antagonists. Eur J Pharm Sci 13:249–259

    Article  PubMed  CAS  Google Scholar 

  • Mikò T, Ligneau X, Pertz HH, Arrang JM, Ganellin CR, Schwartz JC, Schunack W, Stark H (2003) Novel nonimidazole histamine h3 receptor antagonists: 1-(4-(phenoxymethyl)benzyl)piperidines and related compounds. J Med Chem 46:1523–1530

    Article  PubMed  Google Scholar 

  • Mikò T, Ligneau X, Pertz HH, Arrang JM, Ganellin CR, Schwartz JC, Schunack W, Stark H (2004) Structural variations of 1-(4-(phenoxymethyl)benzyl)piperidines as nonimidazole histamine H3 receptor antagonists. Bioorg Med Chem 12:2727–2736

    Article  PubMed  Google Scholar 

  • Schlicker E, Betz R, Göthert M (1988) Histamine H3 receptor-mediated inhibition of serotonin release in the rat brain cortex. Naunyn-Schmideberg’s Arch Pharmacol 337:588–590

    CAS  Google Scholar 

  • Schlicker E, Fink K, Hinterthaner M, Göthert M (1989) Inhibition of noradrenaline release in the rat brain cortex via presynaptic H3 receptors. Naunyn-Schmideberg’s Arch Pharmacol 340:633–638

    Article  CAS  Google Scholar 

  • Schlicker E, Malinowska M, Kathmann M, Göthert M (1994) Modulation of neurotransmitter release histamine H3 heteroreceptors. Fundam Clin Pharmacol 8:128–137

    Article  PubMed  CAS  Google Scholar 

  • Stark H, Sipll W, Ligneau X, Arrang JM, Ganellin CR, Schwartz JC, Schunack W (2001) Different antagonist binding properties of human and rat histamine H3 receptors. Bioorg Med Chem Lett 11:951–954

    Article  PubMed  CAS  Google Scholar 

  • Tkaczyński T (1966) Synthesis of ethylene amines N-hydroxyethylpiperazine and N,N-bis-hydroxyethylpiperazine. Acta Pol Pharm 4:355–357

    Google Scholar 

  • Van der Goot H, Schepers MJ, Sterk GJ, Timmerman H (1992) Isothiourea analogs of histamine as potent agonists or antagonists of the histamine H3-receptor. Eur J Med Chem 27:511–517

    Article  Google Scholar 

  • Van Es A, Stevens W (1965) Mixed carboxylic acid anhydrides: V. Synthesis of alkyl formates. Recl Trav Chim Pays-Bas 84:704–709

    Google Scholar 

  • Vohora D, Pal SN, Pillai KK (2001) Histamine and selective H3-receptor ligands: a possible role in the mechanism and management of epilepsy. Pharmacol Biochem Behav 68:735–741

    Article  PubMed  CAS  Google Scholar 

  • Vollinga RC, Zuiderveld OP, Scheerens H, Bast A, Timmerman H (1992) A simple and rapid in system for the screening of histamine H3-ligands. Methods Find Exp Clin Pharmacol 105:747–751

    Google Scholar 

  • Walczyński K, Guryn R, Timmerman H, Zuiderveld O (1999a) Non-imidazole histamine H3 ligands. Part I. Synthesis of 2-(1-piperazinyl)- and 2-(hexahydro-1H-1,4-diazepin-1-yl)benzothiazole derivatives as H3-antagonists with H1 blocking activities. Il Farmaco 54:684–694

    Article  PubMed  Google Scholar 

  • Walczyński K, Guryn R, Zuiderveld OP, Timmerman H (1999b) Non-imidazole histamine H3 ligands, part 2: new 2-substituted benzothiazoles as histamine H3 antagonists. Arch Pharm Pharm Med Chem 332:389–398

    Article  Google Scholar 

  • Walczyński K, Zuiderveld OP, Timmerman H (2005) Non-imidazole histamine H3 ligands. Part III. New 4-n-propylpiperazines as non-imidazole histamine H3-antagonists. Eur J Med 40:15–23

    Article  Google Scholar 

  • Witkin JM, Nelson DL (2004) Selective histamine H3 receptor antagonists for treatment of cognitive deficiencies and other disorders of the central nervous system. Pharmacol Ther 103:1–20

    Article  PubMed  CAS  Google Scholar 

  • Wulff BS, Hastrup S, Rimvall K (2002) Characteristics of recombinantly expressed rat and human histamine H3 receptors. Eur J Pharmacol 453:33–41

    Article  PubMed  CAS  Google Scholar 

  • Yoshimatsu H, Itateyama E, Kondou S, Tajima D, Himeno K, Hidaka S, Kurokawa M, Sakata T (1999) Hypothalamic neuronal histamine as a target of leptin in feeding behavior. Diabetes 48:2286–2291

    Article  PubMed  CAS  Google Scholar 

  • Zaragoza F, Stephensen H, Peschke B, Rimvall K (2005) 2-(4-Alkylpiperazin-1-yl)quinolines as a new class of imidazole-free histamine H3 receptor antagonists. J Med Chem 48:306–311

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Synthesis and Technology of Drugs, Medical University, Muszyńskiego Street 1, 90-151, Lodz, Poland

    Marek Staszewski & Krzysztof Walczyński

Authors
  1. Marek Staszewski
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Krzysztof Walczyński
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Krzysztof Walczyński.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Staszewski, M., Walczyński, K. 1-Phenoxyalkyl-4-[(N,N-disubstitutedamino)alkyl]piperazine derivatives as non-imidazole histamine H3-antagonists. Med Chem Res 22, 1287–1304 (2013). https://doi.org/10.1007/s00044-012-0090-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00044-012-0090-2

Keywords

Search

Navigation